Alternative splicing of SLAMF6 in human T cells creates a co-stimulatory isoform that counteracts the inhibitory effect of the full-length receptor

SLAMF6 is a homotypic receptor of the Ig-superfamily associated with progenitor exhausted T cells. In humans, SLAMF6 has three splice isoforms involving its V-domain. While the canonical 8-exon receptor inhibits T cell activation through SAP recruitment, the short isoform SLAMF6Δ17-65 has a strong agonistic effect. The costimulatory action depends on protein phosphatase SHP-1 and leads to a cytotoxic molecular profile governed by transcription factors Tbet, Runx3, and Tcf7. In T cells from individual patients treated with immune checkpoint blockade, a shift was noted towards SLAMF6Δ17-65. Splice-switching antisense oligonucleotides designed to target the SLAMF6 splice junction, enhanced SLAMF6Δ17-65 in human tumor-infiltrating lymphocytes and improved their capacity to inhibit human melanoma in mice. The possible emergence of two opposing isoforms from the SLAMF6 gene may represent an immune-modulatory mechanism that can be exploited for cancer immunotherapy.

[1]  E. Hoffman,et al.  Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping , 2020, JAMA neurology.

[2]  N. Hacohen,et al.  SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint , 2020, eLife.

[3]  S. Carmona,et al.  Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells , 2020, Frontiers in Immunology.

[4]  John G. Doench,et al.  Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy , 2019, Nature.

[5]  S. Berger,et al.  TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision. , 2019, Immunity.

[6]  G. Freeman,et al.  PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity , 2019, Nature Immunology.

[7]  Catherine J. Wu,et al.  SLAMF6 as a Regulator of Exhausted CD8+ T Cells in Cancer , 2019, Cancer Immunology Research.

[8]  K. Patrick,et al.  The Splicing Factor hnRNP M Is a Critical Regulator of Innate Immune Gene Expression in Macrophages , 2019, bioRxiv.

[9]  M. Rotival,et al.  Defining the genetic and evolutionary architecture of alternative splicing in response to infection , 2019, Nature Communications.

[10]  Yan Lu,et al.  SLAM receptors foster iNKT cell development by reducing TCR signal strength after positive selection , 2019, Nature Immunology.

[11]  Ziv Shulman,et al.  T cell interactions with B cells during germinal center formation, a three‐step model , 2019, Immunological reviews.

[12]  F. Hodi,et al.  Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade , 2019, Nature Immunology.

[13]  Paul J. Hoover,et al.  Erratum: Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma (Cell (2018) 175(4) (998–1013.e20), (S0092867418313941) (10.1016/j.cell.2018.10.038)) , 2019 .

[14]  Paul J. Hoover,et al.  Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma , 2019, Cell.

[15]  K. E. Lundin,et al.  Chemical Development of Therapeutic Oligonucleotides. , 2019, Methods in molecular biology.

[16]  Paul J. Hoover,et al.  Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma , 2018, Cell.

[17]  Bin Zhang,et al.  ARID5B regulates metabolic programming in human adaptive NK cells , 2018, The Journal of experimental medicine.

[18]  J. Cannons,et al.  X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective , 2018, Front. Immunol..

[19]  R. Finkel,et al.  Nusinersen versus Sham Control in Later‐Onset Spinal Muscular Atrophy , 2018, The New England journal of medicine.

[20]  T. Peretz,et al.  Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity In Vivo , 2018, Cancer Immunology Research.

[21]  B. Ueberheide,et al.  Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor , 2017, Proceedings of the National Academy of Sciences.

[22]  Chun Jimmie Ye,et al.  Genetic analysis of isoform usage in the human anti-viral response reveals influenza-specific regulation of ERAP2 transcripts under balancing selection , 2017, bioRxiv.

[23]  Z. Siegfried,et al.  The role of RNA alternative splicing in regulating cancer metabolism , 2017, Human Genetics.

[24]  Ning Wu,et al.  Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1 , 2016, The Journal of experimental medicine.

[25]  Ning Wu,et al.  Correction: Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1 , 2016, The Journal of experimental medicine.

[26]  Mallory A. Havens,et al.  Splice-switching antisense oligonucleotides as therapeutic drugs , 2016, Nucleic acids research.

[27]  Charles H. Yoon,et al.  Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.

[28]  Ben-Ari FuchsShani,et al.  GeneAnalytics: An Integrative Gene Set Analysis Tool for Next Generation Sequencing, RNAseq and Microarray Data , 2016 .

[29]  Doron Lancet,et al.  GeneAnalytics: An Integrative Gene Set Analysis Tool for Next Generation Sequencing, RNAseq and Microarray Data , 2016, Omics : a journal of integrative biology.

[30]  C. Lenoir,et al.  A hematopoietic cell–driven mechanism involving SLAMF6 receptor, SAP adaptors and SHP-1 phosphatase regulates NK cell education , 2016, Nature Immunology.

[31]  Ning Wu,et al.  SLAM family receptors in normal immunity and immune pathologies. , 2016, Current opinion in immunology.

[32]  Wen J. Li,et al.  Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation , 2015, Nucleic Acids Res..

[33]  A. Porgador,et al.  First Trimester Pregnancy Loss and the Expression of Alternatively Spliced NKp30 Isoforms in Maternal Blood and Placental Tissue , 2015, Front. Immunol..

[34]  Yiming Bao,et al.  NCBI Viral Genomes Resource , 2014, Nucleic Acids Res..

[35]  D. Bates,et al.  Hallmarks of alternative splicing in cancer , 2014, Oncogene.

[36]  V. Cetica,et al.  XLP1 inhibitory effect by 2B4 does not affect DNAM‐1 and NKG2D activating pathways in NK cells , 2014, European journal of immunology.

[37]  David C. Smith,et al.  Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[39]  Henry H. Paik,et al.  Differential splicing across immune system lineages , 2013, Proceedings of the National Academy of Sciences.

[40]  O. Mühlemann,et al.  Nonsense-mediated mRNA decay - mechanisms of substrate mRNA recognition and degradation in mammalian cells. , 2013, Biochimica et biophysica acta.

[41]  A. Burghes,et al.  Antisense oligonucleotides for the treatment of spinal muscular atrophy. , 2013, Human gene therapy.

[42]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[43]  Sven Rahmann,et al.  Snakemake--a scalable bioinformatics workflow engine. , 2012, Bioinformatics.

[44]  Bruce M. Wentworth,et al.  Targeting nuclear RNA for in vivo correction of myotonic dystrophy , 2012, Nature.

[45]  S. Crotty,et al.  The receptor Ly108 functions as a SAP adaptor-dependent on-off switch for T cell help to B cells and NKT cell development. , 2012, Immunity.

[46]  J. Cannons,et al.  Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis. , 2012, Immunity.

[47]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[48]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[49]  S. Tangye,et al.  SLAM family receptors and SAP adaptors in immunity. , 2011, Annual review of immunology.

[50]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[51]  D. Schadendorf,et al.  Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.

[52]  A. Veillette.  SLAM-family receptors: immune regulators with or without SAP-family adaptors. , 2010, Cold Spring Harbor perspectives in biology.

[53]  K. Nichols,et al.  Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. , 2009, The Journal of clinical investigation.

[54]  N. Hacohen,et al.  Regulation of CD45 Alternative Splicing by Heterogeneous Ribonucleoprotein, hnRNPLL , 2008, Science.

[55]  A. Veillette,et al.  Control of T Lymphocyte Signaling by Ly108, a Signaling Lymphocytic Activation Molecule Family Receptor Implicated in Autoimmunity* , 2008, Journal of Biological Chemistry.

[56]  P. Engel,et al.  The SLAM and SAP gene families control innate and adaptive immune responses. , 2008, Advances in immunology.

[57]  S. Rietdijk,et al.  The SLAM-associated protein signaling pathway is required for development of CD4+ T cells selected by homotypic thymocyte interaction. , 2007, Immunity.

[58]  C. Mohan,et al.  Regulation of B Cell Tolerance by the Lupus Susceptibility Gene Ly108 , 2006, Science.

[59]  Transfection of mammalian cells by electroporation , 2006, Nature Methods.

[60]  Eric O Long,et al.  Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). , 2005, Blood.

[61]  R. Clementi,et al.  SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. , 2005, Blood.

[62]  C. June,et al.  SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation1 , 2004, The Journal of Immunology.

[63]  P. Schwartzberg,et al.  Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation , 2003, Nature Cell Biology.

[64]  Qiong Shen,et al.  Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family , 2002, Immunogenetics.

[65]  Massimo Morra,et al.  Structural basis for the interaction of the free SH2 domain EAT‐2 with SLAM receptors in hematopoietic cells , 2001, The EMBO journal.

[66]  L. Notarangelo,et al.  NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. , 2001, The Journal of experimental medicine.

[67]  T. Pawson,et al.  Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product , 2001, Nature Immunology.

[68]  K. Nichols,et al.  CD150 Association with Either the SH2-Containing Inositol Phosphatase or the SH2-Containing Protein Tyrosine Phosphatase Is Regulated by the Adaptor Protein SH2D1A1 , 2001, The Journal of Immunology.